Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits by Andrew Stawasz, Andrew Stawasz, Liping Huang, Paige Kirby, David Bloom, David Bloom

Subjects: Get full text

Comment on “Effectiveness of a Group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: a retrospective cohort study, Vacci... by Chris Kenyon

Subjects: Get full text

Aceptación y desigualdades socioeconómicas en la vacunación frente a meningococo B en la Comunidad de Madrid en el periodo anterior a su inclusión en el calendario by Marta Ijalba Martínez, María Dolores Lasheras Carbajo, Sara Santos Sanz, Diana Gómez Barroso

Subjects: Get full text

Vaccination against meningitis B: is it worth it? by Peter English

Subjects: Get full text

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review by Véronique Abitbol, Woo-Yun Sohn, Michael Horn, Marco Aurelio P. Safadi

Subjects: Get full text

Disparities in healthcare providers’ interpretations and implementations of ACIP’s meningococcal vaccine recommendations by Liping Huang, Amir Goren, Lulu K. Lee, Vicky W. Li, Amanda Dempsey, Amit Srivastava

Subjects: Get full text